« Back
Home /
RVX-208

RVX-208

Item no.	M2219-20mg
Manufacturer	AbMole
CASRN	1044870-39-4
Amount	20mg
Category	Oncology Metabolism Cholesterol & Lipid Metabolism Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	RVX000222;Apabetalone
Similar products	RVX-208, RVX000222
Available
Target Information	Epigenetic Reader Domain
Molecular Weight	370, 4
Solubility	DMSO 60 mg/mL
Bioactivity information	RVX-208 is a first-in-class, small molecule inhibitor of BET bromodomain with IC50 of 0.51 μM for BD2.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2219-20mg-safety-datasheet.pdf